Breast Cancer Clinical Trials in New York, NY

Breast Cancer Clinical Trials in New York, NY

View the best 10 breast cancer medical studies in New York, New York. Access promising new therapies by applying to a New York-based Breast Cancer clinical trial.

Top rated breast cancer clinical trials in New York, New York

Here are the top 10 medical studies for breast cancer in New York, New York

Image of Memorial Sloan Kettering Cancer Center in New York, United States.

OTS167PO

Protein Kinase Inhibitor

Recruiting1 awardPhase 1
This trial is testing a new drug to see what the maximum tolerated dose is for patients with relapsed or refractory breast cancer.
Image of University of Alabama at Birmingham in Birmingham, United States.

Risk-based Breast Cancer Screening Schedule

Behavioural Intervention

Recruiting1 award4 criteria
This trial is comparing annual breast cancer screening to a risk-based breast cancer screening schedule. The goal is to see if the risk-based schedule detects breast cancers earlier and causes fewer false positives.
Image of Mount Sinai Downtown in New York, United States.

Carboplatin

Alkylating agents

Recruiting3 awardsPhase 2
This trial will compare the safety and effectiveness of carboplatin to a combination of carboplatin and everolimus for the treatment of advanced TNBC.
Image of Memorial Sloan Kettering Cancer Center in New York, United States.

1

Recruiting0 awards4 criteria
This trial is looking at whether there is any link between cancer and genes. It is designed to help create ideas for future research.
Image of California Protons Cancer Therapy Center in San Diego, United States.

Proton Radiotherapy

Proton Beam Therapy

Recruiting1 awardPhase 2
This trial will compare the effects of proton radiation therapy on women with early stage breast cancer.
Image of NYU Langone Medical Center in New York, United States.

PBI Radiotherapy 6 Gy +1 More

Brachytherapy

Recruiting1 award3 criteria
This trial is testing a new, more intensive radiation therapy regimen to see if it is as effective and safe as the standard treatment.
Image of Dignity Health St Joseph's Hospital and Medical Center in Phoenix, United States.

Entrectinib

Tyrosine Kinase Inhibitor

Recruiting1 awardPhase 2
This trial is testing a new drug, entrectinib, for patients with different types of solid tumors that have a gene fusion. Patients will be assigned to different groups depending on their tumor type and gene fusion.
Image of Alta Bates Summit Medical Center-Herrick Campus in Berkeley, United States.

Intraoperative Radiation Therapy

Brachytherapy

Recruiting1 award2 criteria
This trial is testing a new way to give radiation therapy for breast cancer that may be as effective as the standard way, and has fewer side effects.
Image of University of Alabama at Birmingham in Birmingham, United States.

Ruxolitinib

Janus Kinase (JAK) Inhibitor

Recruiting0 awardsPhase 2
This trial is testing if the drug ruxolitinib can kill premalignant breast cells. Half the participants will get the drug and half will get a placebo for 15 days, then all will have surgery to remove the cells.
Image of UAB Comprehensive Cancer Center in Birmingham, United States.

Fulvestrant +2 More

Selective Estrogen Receptor Downregulator

Recruiting1 awardPhase 2
This trial is studying whether fulvestrant is more effective than anastrozole or tamoxifen in reducing Ki67 in ILC and whether that Ki67 reduction will correlate with alterations in expression of ER and ER-regulated genes.

Popular filter options for breast-cancer new-york trials

Phase 3 Clinical Trials

View 100 phase 3 medical studies.

Clinical Trials With No Placebo

View 100 medical studies that do not have a placebo group.

View More Breast-cancer New-york Trials

See another 83 medical studies focused on breast-cancer new-york.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.